- As CEO of Retrophin, Martin Shkreli bought an old rare-disease drug, Thiola, and raised the price 2000%. Now at, Turing Pharmaceuticals, he's bought old drug and boosted the price 5000%. http://www.fiercebiotech.com/story/why-would-martin-shkreli-hike-old-drug-price-5000-only-moron-would-ask/2015-09-20 10 comments technology
Linking pages
- Hedge fund trader Martin Shkreli hits back at critics after raising price of HIV drug by 5,000% | The Independent | The Independent http://www.independent.co.uk/news/people/hedge-fund-trader-martin-shkreli-hits-back-at-critics-after-raising-price-of-hiv-drug-by-5000-10511960.html?cmpid=facebook-post 5808 comments
- CEO who raised price of old pill more than $700 calls journalist a ‘moron’ for asking why - The Washington Post https://www.washingtonpost.com/news/to-your-health/wp/2015/09/21/ceo-of-company-that-raised-the-price-of-old-pill-hundreds-of-dollars-overnight-calls-journalist-a-moron-for-asking-why/ 3009 comments
Linked pages
Related searches:
Search whole site: site:www.fiercebiotech.com
Search title: Why would Martin Shkreli hike an old drug price by 5000%? Only a 'moron' would ask | Fierce Biotech
See how to search.